Jason Kelly, the Co-founder and CEO of Ginkgo Bioworks, and Michelle Rozo, VP of Technical Capabilities at In-Q-Tel, dive deep into the world of biotechnology. They discuss how the U.S. government transformed biotech into a $1 trillion industry and explore the transformative potential of AI in drug discovery. The duo also examines China’s growing ambitions in this field, raising questions about U.S. competitiveness. Additionally, they highlight ethical challenges and the need for strategic policies to foster innovation and enhance national security.